- Home
- CVAC vs OCFC Comparison
CVAC vs OCFC Comparison
Compare CVAC & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- OCFC
- Stock Information
- Founded
- CVAC 2000
- OCFC 1902
- Country
- CVAC Germany
- OCFC United States
- Employees
- CVAC N/A
- OCFC N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- OCFC Major Banks
- Sector
- CVAC Health Care
- OCFC Finance
- Exchange
- CVAC Nasdaq
- OCFC Nasdaq
- Market Cap
- CVAC 1.2B
- OCFC 1.0B
- IPO Year
- CVAC 2020
- OCFC 1996
- Fundamental
- Price
- CVAC $5.34
- OCFC $18.34
- Analyst Decision
- CVAC Hold
- OCFC Buy
- Analyst Count
- CVAC 3
- OCFC 5
- Target Price
- CVAC $6.83
- OCFC $21.60
- AVG Volume (30 Days)
- CVAC 574.2K
- OCFC 490.3K
- Earning Date
- CVAC 11-12-2025
- OCFC 10-22-2025
- Dividend Yield
- CVAC N/A
- OCFC 4.36%
- EPS Growth
- CVAC N/A
- OCFC N/A
- EPS
- CVAC 1.01
- OCFC 1.30
- Revenue
- CVAC $599,540,810.00
- OCFC $378,558,000.00
- Revenue This Year
- CVAC N/A
- OCFC N/A
- Revenue Next Year
- CVAC $23.40
- OCFC $12.81
- P/E Ratio
- CVAC $5.32
- OCFC $14.13
- Revenue Growth
- CVAC 675.15
- OCFC N/A
- 52 Week Low
- CVAC $2.37
- OCFC $14.29
- 52 Week High
- CVAC $5.72
- OCFC $21.87
- Technical
- Relative Strength Index (RSI)
- CVAC 51.18
- OCFC 51.63
- Support Level
- CVAC $5.17
- OCFC $17.77
- Resistance Level
- CVAC $5.41
- OCFC $18.38
- Average True Range (ATR)
- CVAC 0.05
- OCFC 0.49
- MACD
- CVAC -0.00
- OCFC -0.04
- Stochastic Oscillator
- CVAC 70.82
- OCFC 34.31
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.